Lipid lowering and Alzheimer disease risk: A mendelian randomization study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid lowering and Alzheimer disease risk: A mendelian randomization study
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 87, Issue 1, Pages 30-39
Publisher
Wiley
Online
2019-11-13
DOI
10.1002/ana.25642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
- (2019) Brian W. Kunkle et al. NATURE GENETICS
- PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
- (2018) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer’s Disease? A Systematic Review and Meta-Analysis
- (2018) Susanna C. Larsson et al. JOURNAL OF ALZHEIMERS DISEASE
- Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study
- (2018) Debora Rizzuto et al. JOURNAL OF ALZHEIMERS DISEASE
- The MR-Base platform supports systematic causal inference across the human phenome
- (2018) Gibran Hemani et al. eLife
- Midlife Vascular Risk Factors and the Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Xiang-Fei Meng et al. JOURNAL OF ALZHEIMERS DISEASE
- Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants
- (2017) Stephen Burgess et al. EPIDEMIOLOGY
- Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables
- (2017) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data
- (2017) Olena O Yavorska et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
- (2017) Clifford R Jack et al. LANCET NEUROLOGY
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
- (2017) Susanna C Larsson et al. BMJ-British Medical Journal
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis
- (2017) Susanna C Larsson et al. BMJ-British Medical Journal
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: Effect on stroke risk
- (2016) Haralampos Milionis et al. European Journal of Internal Medicine
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
- (2016) Jack Bowden et al. GENETIC EPIDEMIOLOGY
- Selecting instruments for Mendelian randomization in the wake of genome-wide association studies
- (2016) Daniel I Swerdlow et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Association Between Low-Density Lipoprotein Cholesterol–Lowering Genetic Variants and Risk of Type 2 Diabetes
- (2016) Luca A. Lotta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection and interpretation of shared genetic influences on 42 human traits
- (2016) Joseph K Pickrell et al. NATURE GENETICS
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
- (2016) Johannes Kettunen et al. Nature Communications
- The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
- (2015) Michael J. Lipinski et al. EUROPEAN HEART JOURNAL
- Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors
- (2015) Stephen Burgess et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
- (2015) J. Bowden et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
- (2015) Søren D. Østergaard et al. PLOS MEDICINE
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
- (2013) Jon B. Toledo et al. BRAIN
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
- (2013) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
- (2013) Bruce Reed et al. JAMA Neurology
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Cognitive reserve in ageing and Alzheimer's disease
- (2012) Yaakov Stern LANCET NEUROLOGY
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- Association of Alzheimer disease pathology with abnormal lipid metabolism: The Hisayama Study
- (2011) T. Matsuzaki et al. NEUROLOGY
- PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1
- (2008) Mary Cabell Jonas et al. EMBO REPORTS
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
- (2007) Debbie A. Lawlor et al. STATISTICS IN MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started